Review



control small molecule remdesivir  (Gilead Sciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Gilead Sciences control small molecule remdesivir
    IC 50 values of standard CYP substrate inhibitors and <t> remdesivir </t> for CYP3A4, 2C8, and 2D6 isoenzymes.
    Control Small Molecule Remdesivir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 15423 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+small+molecule+remdesivir/VEKLURY/pmc09597875-96-3-5
    Average 99 stars, based on 15423 article reviews
    control small molecule remdesivir - by Bioz Stars, 2026-09
    99/100 stars

    Images

    1) Product Images from "In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19"

    Article Title: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19

    Journal: Frontiers in Pharmacology

    doi: 10.3389/fphar.2022.973768

    IC 50 values of standard CYP substrate inhibitors and remdesivir for CYP3A4, 2C8, and 2D6 isoenzymes.
    Figure Legend Snippet: IC 50 values of standard CYP substrate inhibitors and remdesivir for CYP3A4, 2C8, and 2D6 isoenzymes.

    Techniques Used:

    Effect of (A) ketoconazole (5.00–0.0005 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP3A4-mediated hydroxylation of testosterone. The graphs have been plotted for log conc. vs . percentage of inhibition.
    Figure Legend Snippet: Effect of (A) ketoconazole (5.00–0.0005 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP3A4-mediated hydroxylation of testosterone. The graphs have been plotted for log conc. vs . percentage of inhibition.

    Techniques Used: Inhibition

    IC 50 values of Withania somnifera and AYUSH-64 extracts for CYP3A4, 2C8, and 2D6 isoenzymes.
    Figure Legend Snippet: IC 50 values of Withania somnifera and AYUSH-64 extracts for CYP3A4, 2C8, and 2D6 isoenzymes.

    Techniques Used:

    Effect of (A) rosiglitazone (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2C8-mediated hydroxylation of paclitaxel. The graphs have been plotted for log conc. vs . percentage of inhibition.
    Figure Legend Snippet: Effect of (A) rosiglitazone (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2C8-mediated hydroxylation of paclitaxel. The graphs have been plotted for log conc. vs . percentage of inhibition.

    Techniques Used: Inhibition

    Effect of (A) quinidine (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2D6-mediated hydroxylation of dextromethorphan. The graphs have been plotted for log conc. vs. percentage of inhibition.
    Figure Legend Snippet: Effect of (A) quinidine (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2D6-mediated hydroxylation of dextromethorphan. The graphs have been plotted for log conc. vs. percentage of inhibition.

    Techniques Used: Inhibition



    Similar Products

    control small molecule remdesivir  (Gilead Sciences)
    99
    Gilead Sciences control small molecule remdesivir
    IC 50 values of standard CYP substrate inhibitors and <t> remdesivir </t> for CYP3A4, 2C8, and 2D6 isoenzymes.
    Control Small Molecule Remdesivir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+small+molecule+remdesivir/VEKLURY/pmc09597875-96-3-5
    Average 99 stars, based on 1 article reviews
    control small molecule remdesivir - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier
    case control small molecule remdesivir  (Gilead Sciences)
    99
    Gilead Sciences case control small molecule remdesivir
    IC 50 values of standard CYP substrate inhibitors and <t> remdesivir </t> for CYP3A4, 2C8, and 2D6 isoenzymes.
    Case Control Small Molecule Remdesivir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+small+molecule+remdesivir/VEKLURY/ppr0436510-128-17-21
    Average 99 stars, based on 1 article reviews
    case control small molecule remdesivir - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    IC 50 values of standard CYP substrate inhibitors and remdesivir for CYP3A4, 2C8, and 2D6 isoenzymes.

    Journal: Frontiers in Pharmacology

    Article Title: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19

    doi: 10.3389/fphar.2022.973768

    Figure Lengend Snippet: IC 50 values of standard CYP substrate inhibitors and remdesivir for CYP3A4, 2C8, and 2D6 isoenzymes.

    Article Snippet: The concentration of case–control small-molecule remdesivir was prepared in a range of 1–1,000 ng/ml ( ).

    Techniques:

    Effect of (A) ketoconazole (5.00–0.0005 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP3A4-mediated hydroxylation of testosterone. The graphs have been plotted for log conc. vs . percentage of inhibition.

    Journal: Frontiers in Pharmacology

    Article Title: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19

    doi: 10.3389/fphar.2022.973768

    Figure Lengend Snippet: Effect of (A) ketoconazole (5.00–0.0005 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP3A4-mediated hydroxylation of testosterone. The graphs have been plotted for log conc. vs . percentage of inhibition.

    Article Snippet: The concentration of case–control small-molecule remdesivir was prepared in a range of 1–1,000 ng/ml ( ).

    Techniques: Inhibition

    IC 50 values of Withania somnifera and AYUSH-64 extracts for CYP3A4, 2C8, and 2D6 isoenzymes.

    Journal: Frontiers in Pharmacology

    Article Title: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19

    doi: 10.3389/fphar.2022.973768

    Figure Lengend Snippet: IC 50 values of Withania somnifera and AYUSH-64 extracts for CYP3A4, 2C8, and 2D6 isoenzymes.

    Article Snippet: The concentration of case–control small-molecule remdesivir was prepared in a range of 1–1,000 ng/ml ( ).

    Techniques:

    Effect of (A) rosiglitazone (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2C8-mediated hydroxylation of paclitaxel. The graphs have been plotted for log conc. vs . percentage of inhibition.

    Journal: Frontiers in Pharmacology

    Article Title: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19

    doi: 10.3389/fphar.2022.973768

    Figure Lengend Snippet: Effect of (A) rosiglitazone (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2C8-mediated hydroxylation of paclitaxel. The graphs have been plotted for log conc. vs . percentage of inhibition.

    Article Snippet: The concentration of case–control small-molecule remdesivir was prepared in a range of 1–1,000 ng/ml ( ).

    Techniques: Inhibition

    Effect of (A) quinidine (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2D6-mediated hydroxylation of dextromethorphan. The graphs have been plotted for log conc. vs. percentage of inhibition.

    Journal: Frontiers in Pharmacology

    Article Title: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19

    doi: 10.3389/fphar.2022.973768

    Figure Lengend Snippet: Effect of (A) quinidine (100–0.01 μM/ml), (B) remdesivir (1,000–1 ng/ml), (C) remdesivir + AYUSH-64 (2001–1.001 μg/ml), (D) AYUSH-64 (2000–1 μg/ml), (E) Withania somnifera (2000–1 μg/ml), and (F) remdesivir + Withania somnifera (2001–1.001 μg/ml) on CYP2D6-mediated hydroxylation of dextromethorphan. The graphs have been plotted for log conc. vs. percentage of inhibition.

    Article Snippet: The concentration of case–control small-molecule remdesivir was prepared in a range of 1–1,000 ng/ml ( ).

    Techniques: Inhibition